The Gen-Val Project is a biotechnological consortium made up of four business organisations which combine scientific-technological capacities such as sequencing (Lifesequencing, S.L.), bioinformatics (Biotech Vana, S.L. and Celeromics, S.L.) and genetic diagnoses (Igenomix, S.L. – which is included in the group of researchers at IVI (the Valencian Infertility Institute). This consortium aims to provide the health sector with a permanent advanced genetic diagnosis and prognosis service that is capable of diagnosing diseases or metabolopathies of a hereditary origin with a view to being able to research into more palliative and personalised treatments of these illnesses.